Drug development times not correlated with drug prices
First ASPE guidelines for diabetic peripheral neuropathic pain
Controversy in the US over human papillomavirus vaccines
New AAN guidelines for Parkinson's disease
The Food and Drug Control Agency (BPOM) in Indonesia have warned consumers that prescription drugs are being sold in some stores as over-the-counter (OTC) medications,
The flap over the avian flu
The US National Comprehensive Cancer Network (NCCN) released new guidelines which outline the diagnosis, treatment, and prevention of venous thromboembolic disease (VTE)
Echocardiography strategy attractive for endocarditis stroke prevention
Psychiatric disorders under-treated in Lebanon
LMWH cost saving in patients with AF undergoing cardioversion
Treatment of periodontal disorders is associated with lower chronic disease-related costs,
Initiating rasagiline worth it in early Parkinson's disease
Amlodipine may be worth it for patients with CAD ...
Leflunomide + methotrexate cost effective for RA in Korea
Perindopril cost effective for CAD in the UK
Intervention programme curbs antibacterial use and costs in Thailand
The use of proton pump inhibitors (PPIs) in patients with non-variceal upper GI haemorrhage is not cost effective compared with histamine H2-receptor antagonists (H2RAs) in Taiwan,
Tenecteplase-facilitated PCI cost effective vs tenecteplase alone
Irbesartan: the earlier the better for preventing diabetic nephropathies
Room to improve paediatric hospital care in CIS countries
Epoetin alfa given 3x/week cost saving in anaemia
Methylphenidate use rises markedly among Israeli children
Well-behaved guideline improves thromboprophylaxis rates
The prevalence of erythromycin resistance of Streptococcus pyogenes is strongly associated with recent use of macrolides,
Bortezomib improves QOL in multiple myeloma
Salmeterol/fluticasone propionate preferred for asthma
Infliximab has an impact on psoriatic arthritis QOL
Funding for adefovir dipivoxil [Hepsera] has been approved, and access to lamivudine [Zeffix] has been widened, for the treatment of patients in New Zealand with hepatitis B
Outlook variable in Japanese pharma markets
The battle between brand-name and generic drugs
The recently launched Public Health Foundation of India is set to use both public funds and private donations to improve education, training and research in the public health sector;
Zambia has introduced free healthcare for people in rural regions
Pharmaceutical growth is expected in the Middle East due to economic liberalisation and mass health insurance,
Genzyme lends a helping hand...